AMGN vs REG · P/E 24, rev $36.75B vs P/E 34, $12.93B cap
Amgen Inc (AMGN) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
REG does not have a complete income-statement cache yet.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the AMGN and REG stock pages for the full models.
Not investment advice.